Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGMB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101930373 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
USP27X-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NCAPH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DRC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H3F3AP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR4745 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRHDE-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WNT9A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIA-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADGRB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on